%0 Journal Article
%T 经尿道等离子前列腺剜除术治疗高龄危重前列腺增生(附86例报告)<br>
Treatment of Severe Prostatic Hyperplasia with High-Risk Factors by Transurethral Resectoscope Enucleation of Prostate (TUERP) (Report of 86 Cases)
%A 王悦
%A 许小林
%A 刘峰
%A 陈琳
%A 刘林涛
%J Asian Case Reports in Surgery
%P 1-4
%@ 2169-2548
%D 2013
%I Hans Publishing
%R 10.12677/ACRS.2013.21001
%X <p style=\"text-align:justify;\">
	目的：探讨治疗高危且伴有前列腺增生症(BPH)患者安全、有效的手术方法。方法：对我院2010~2012年86例高龄重度前列腺增生且伴有全身重要脏器疾病的患者用经尿道等离子前列腺剜除术(TUERP)治疗。结果：切除组织重量30~110 g，平均60.8 g，手术时间35~105 min，平均87.5 min，术中无明显出血，无手术并发症病例。随访6~48个月，术后的IPSS、Qmax、残余尿改善明显(P &lt; 0.01)。结论：TUERP是治疗高危重度前列腺增生安全、有效的手术方法。
</p>
<p>
	<br />
</p>
<p class=\"MsoNormal\" style=\"text-align:justify;\">
	Objective: To investigate the safe and effective management of large volume benign prostatic hyperplasia (BPH) with high-risk factors. Methods: We analyzed retrospectively 86 old patients of severe BPH accompanied with complicated underlying diseases. The all cases were underwent TUERP in our hospital from 2010 to 2012. Results: The weight of resected tissue was 30 - <!--?xml:namespace prefix = st1 /--><st1:chmetcnv w:st=\"on\" tcsc=\"0\" numbertype=\"1\" negative=\"False\" hasspace=\"True\" sourcevalue=\"110\" unitname=\"g\">110 g</st1:chmetcnv>. Time of operation was 35 - 105 min. There was little bleeding and no compli- cations happened in-operation or post-operation in this group. A<st1:chmetcnv w:st=\"on\" tcsc=\"0\" numbertype=\"1\" negative=\"False\" hasspace=\"False\" sourcevalue=\"1\" unitname=\"l\">1l</st1:chmetcnv> patients were followed-up 6 to 48 Months, the IPSS and volume of urine retention had dropped, and Qmax had increased after operation obviously (P &lt; 0.01). Conclusion: Transurethral resectoscope enucleation of prostate is safe and effective to treat high and large volume BPH accompa- nied with high-risk facts.<!--?xml:namespace prefix = o /--><o:p></o:p> 
</p>
<div style=\"text-align:justify;\">
	<br />
</div>
<p>
	<br />
</p>
%K 经尿道等离子前列腺剜除术；高危；前列腺增生<br>
Transurethral Resectoscope Enucleation of Prostate
%K High-Risk Factor
%K Benign Prostatic Hyperplasia
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=9672